Insys Therapeutics - 18 Year Stock Price History | INSY

Historical daily share price chart and data for Insys Therapeutics since 2000 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Insys Therapeutics as of November 19, 2018 is 6.72.
Insys Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 7.8298 11.5300 13.3800 5.7600 6.7200 -30.15%
2017 9.8283 9.8600 14.7000 4.9700 9.6200 4.57%
2016 14.9835 28.0500 28.0500 9.0700 9.2000 -67.87%
2015 30.5712 21.0950 44.9200 21.0950 28.6300 35.82%
2014 17.8493 13.3267 27.7900 11.3000 21.0800 63.37%
2013 7.3685 2.5000 16.3600 2.3667 12.9033 399.49%
2012 3.3651 3.3367 6.2333 2.3333 2.5833 -13.89%
2011 4.7088 5.2867 7.8080 1.3333 3.0000 -45.36%
2010 6.4800 6.5067 8.9467 4.4733 5.4900 -6.90%
2009 4.5419 3.4567 10.9800 0.7117 5.8967 78.90%
2008 8.9350 13.0133 17.4846 2.0333 3.2960 -72.53%
2007 26.9241 35.3800 46.7667 11.9967 11.9967 -64.67%
2006 141.1875 222.8533 253.5567 33.9567 33.9567 -84.52%
2005 208.9988 247.4567 310.8967 148.0267 219.3967 -13.75%
2004 256.5310 365.1867 451.1967 99.4300 254.3700 -31.34%
2003 273.8244 187.4203 388.3667 155.2406 370.4733 106.64%
2002 259.8843 425.9391 438.3159 174.3362 179.2870 -59.52%
2001 342.7820 586.6930 586.6930 222.4611 442.9130 -27.26%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.499B $0.141B
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $123.892B 25.10
Medtronic (MDT) Ireland $122.046B 18.71
Stryker (SYK) United States $62.759B 23.66
Boston Scientific (BSX) United States $48.834B 24.68
Baxter (BAX) United States $34.600B 22.34
Zimmer Biomet Holdings (ZBH) United States $23.151B 15.01
Smith & Nephew SNATS (SNN) United Kingdom $15.845B 0.00
ResMed (RMD) United States $14.616B 27.87
Perrigo (PRGO) Ireland $8.530B 12.95
Bio-Rad Laboratories (BIO) United States $8.041B 51.42
Canopy Growth (CGC) Canada $7.608B 0.00
Hill-Rom Holdings (HRC) United States $6.079B 19.27
Aurora Cannabis (ACB) Canada $5.873B 32.05
Haemonetics (HAE) United States $5.316B 46.75
ICU Medical (ICUI) United States $4.835B 26.94
Insulet (PODD) United States $4.492B 0.00
Hutchison China MediTech (HCM) China $4.108B 0.00
Agios Pharmaceuticals (AGIO) United States $3.867B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.782B 0.00
Neogen (NEOG) United States $3.211B 48.63
NuVasive (NUVA) United States $3.153B 29.33
National Vision Holdings (EYE) United States $2.871B 55.54
Quidel (QDEL) United States $2.378B 31.00
Aphria (APHA) $2.260B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.371B 19.41
AtriCure (ATRC) United States $1.182B 0.00
Cardiovascular Systems (CSII) United States $0.999B 1439.50
VAREX IMAGING (VREX) United States $0.974B 19.57
Meridian Bioscience (VIVO) United States $0.833B 26.55
OraSure Technologies (OSUR) United States $0.761B 42.86
Surmodics (SRDX) United States $0.759B 115.98
Eagle Pharmaceuticals (EGRX) United States $0.737B 23.64
MacroGenics (MGNX) United States $0.713B 0.00
PetIQ (PETQ) United States $0.704B 20.01
Cerus (CERS) United States $0.692B 0.00
Lantheus Holdings (LNTH) United States $0.627B 19.41
Omeros (OMER) United States $0.617B 0.00
Owens & Minor (OMI) United States $0.546B 6.18
LeMaitre Vascular (LMAT) United States $0.537B 26.39
NanoString Technologies (NSTG) United States $0.509B 0.00
TG Therapeutics (TGTX) United States $0.428B 0.00
Evolus (EOLS) United States $0.377B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.342B 22.12
Cytosorbents (CTSO) United States $0.316B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.258B 0.00
Surface Oncology (SURF) United States $0.230B 0.00
Rockwell Medical (RMTI) United States $0.205B 0.00
Bovie Medical (BVX) United States $0.193B 0.00
BioLife Solutions (BLFS) United States $0.186B 250.75
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.116B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.080B 16.68
Female Health (VERU) United States $0.074B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.072B 0.00
InfuSystems Holdings (INFU) United States $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.059B 18.87
CAS Medical Systems (CASM) United States $0.051B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.023B 0.00
Akers Biosciences Inc (AKER) United States $0.022B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.017B 0.00
Senestech (SNES) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00